Mallinckrodt considers generics bankruptcy: RPT

Drugmaker Mallinckrodt is reportedly considering placing its U.S. generic-drug business into bankruptcy. Yahoo Finance's Seana Smith, Jared Blikre and Dan Roberts discuss.